Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Immune Design Corp. (IMDZ) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/12/2019 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
04/09/2019 EFFECT Form EFFECT - Notice of Effectiveness:
04/04/2019 4 BERGER FRANKLIN M (Director) has filed a Form 4 on IMMUNE DESIGN CORP.
Txns: Disposed/sold 75,000 shares @ $5.85, valued at $438.8k
Disposed/sold 10,000 options to buy @ $5.6, valued at $56k
Disposed/sold 12,500 options to buy @ $4.05, valued at $50.6k
Disposed/sold 12,500 options to buy @ $1.31, valued at $16.4k
04/04/2019 4 BALTIMORE DAVID (Director) has filed a Form 4 on IMMUNE DESIGN CORP.
Txns: Disposed/sold 78,287 shares @ $5.85, valued at $458k
Disposed/sold 3,058 options to buy @ $1.48, valued at $4.5k
Disposed/sold 4,281 options to buy @ $1.23, valued at $5.3k
Disposed/sold 10,000 options to buy @ $5.6, valued at $56k
Disposed/sold 12,500 options to buy @ $4.05, valued at $50.6k
Disposed/sold 12,500 options to buy @ $1.31, valued at $16.4k
04/04/2019 4 Yurasov Sergey (Sr. VP, Clinic. Devel. & CMO) has filed a Form 4 on IMMUNE DESIGN CORP.
Txns: Disposed/sold 6,136 shares @ $5.85, valued at $35.9k
Disposed/sold 72,620 restricted stock units @ $0
Disposed/sold 110,000 options to buy @ $4.05, valued at $445.5k
Disposed/sold 113,335 options to buy @ $4.4, valued at $498.7k
Disposed/sold 110,000 options to buy @ $1.31, valued at $144.1k
04/04/2019 4 Brady Stephen R (EVP, Strategy & Finance) has filed a Form 4 on IMMUNE DESIGN CORP.
Txns: Disposed/sold 17,063 shares @ $5.85, valued at $99.8k
Disposed/sold 79,536 restricted stock units @ $0
Disposed/sold 116,819 options to buy @ $1.23, valued at $143.7k
Disposed/sold 100,000 options to buy @ $4.05, valued at $405k
Disposed/sold 184,364 options to buy @ $4.4, valued at $811.2k
Disposed/sold 120,000 options to buy @ $1.31, valued at $157.2k
04/04/2019 4 Gombotz Wayne (Chief Development Officer) has filed a Form 4 on IMMUNE DESIGN CORP.
Txns: Disposed/sold 37,068 shares @ $0
Disposed/sold 38,715 options to buy @ $1.31, valued at $50.7k
Disposed/sold 6,116 options to buy @ $1.48, valued at $9.1k
Disposed/sold 40,697 options to buy @ $1.23, valued at $50.1k
Disposed/sold 32,083 options to buy @ $5.6, valued at $179.7k
Disposed/sold 11,407 options to buy @ $4.4, valued at $50.2k
04/04/2019 4 Paya Carlos V (President and CEO) has filed a Form 4 on IMMUNE DESIGN CORP.
Txns: Disposed/sold 35,576 shares @ $5.85, valued at $208.1k
Disposed/sold 121,000 restricted stock units @ $0
Disposed/sold 195,289 options to buy @ $1.31, valued at $255.8k
Disposed/sold 67,277 options to buy @ $1.31, valued at $88.1k
Disposed/sold 61,161 options to buy @ $1.48, valued at $90.5k
Disposed/sold 244,648 options to buy @ $1.23, valued at $300.9k
Disposed/sold 175,000 options to buy @ $5.6, valued at $980k
Disposed/sold 216,500 options to buy @ $4.05, valued at $876.8k
Disposed/sold 263,009 options to buy @ $4.4, valued at $1.2M
Disposed/sold 293,000 options to buy @ $1.31, valued at $383.8k
04/04/2019 4 ter Meulen Jan Henrik (Chief Scientific Officer) has filed a Form 4 on IMMUNE DESIGN CORP.
Txns: Disposed/sold 14,620 shares @ $5.85, valued at $85.5k
Disposed/sold 69,362 restricted stock units @ $0
Disposed/sold 98,837 options to buy @ $1.23, valued at $121.6k
Disposed/sold 70,000 options to buy @ $5.6, valued at $392k
Disposed/sold 90,000 options to buy @ $4.05, valued at $364.5k
Disposed/sold 46,788 options to buy @ $4.4, valued at $205.9k
Disposed/sold 120,000 options to buy @ $1.31, valued at $157.2k
04/04/2019 4 Kelley Susan L. (Director) has filed a Form 4 on IMMUNE DESIGN CORP.
Txns: Disposed/sold 10,000 options to buy @ $5.6, valued at $56k
Disposed/sold 12,500 options to buy @ $4.05, valued at $50.6k
Disposed/sold 12,500 options to buy @ $1.31, valued at $16.4k
04/04/2019 4 PENHOET EDWARD (Director) has filed a Form 4 on IMMUNE DESIGN CORP.
Txns: Disposed/sold 3,058 options to buy @ $1.48, valued at $4.5k
Disposed/sold 4,281 options to buy @ $1.23, valued at $5.3k
Disposed/sold 10,000 options to buy @ $5.6, valued at $56k
Disposed/sold 12,500 options to buy @ $4.05, valued at $50.6k
Disposed/sold 12,500 options to buy @ $1.31, valued at $16.4k
04/04/2019 4 RINGO WILLIAM R (Director) has filed a Form 4 on IMMUNE DESIGN CORP.
Txns: Disposed/sold 10,000 options to buy @ $5.6, valued at $56k
Disposed/sold 12,500 options to buy @ $4.05, valued at $50.6k
Disposed/sold 12,500 options to buy @ $1.31, valued at $16.4k
04/04/2019 4 COLEMAN LEWIS W (Director) has filed a Form 4 on IMMUNE DESIGN CORP.
Txns: Disposed/sold 175,000 shares @ $5.85, valued at $1M
Disposed/sold 3,000 shares @ $5.85, valued at $17.6k
Disposed/sold 10,000 options to buy @ $5.6, valued at $56k
Disposed/sold 12,500 options to buy @ $4.05, valued at $50.6k
Disposed/sold 12,500 options to buy @ $1.31, valued at $16.4k
04/02/2019 4 COLUMN GROUP L P (10% Owner) has filed a Form 4 on IMMUNE DESIGN CORP.
Txns: Unknown transaction of 6,642,942 shares @ $5.85, valued at $38.9M
04/02/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/02/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/02/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/02/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/02/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/02/2019 POS AM Form POS AM - Post-Effective amendments for registration statement:
04/02/2019 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
04/02/2019 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of Immune Design Corp",
"Amended and Restated Bylaws of Immune Design Corp"
04/02/2019 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
04/02/2019 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/28/2019 10-K/A Annual Report for the period ended December 31, 2018 [amend]
03/26/2019 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/20/2019 GN Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Civitas, Entegra, and Immune Design on Behalf of Stockholders and Encourages Investors to Contact the Firm
03/15/2019 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/15/2019 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/13/2019 10-K Annual Report for the period ended December 31, 2018
03/11/2019 SC 13G/A EcoR1 Capital, LLC reports a 0% stake in Immune Design Corp.
03/05/2019 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
03/05/2019 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
02/28/2019 SC 13D/A Versant Venture Capital III, L.P. reports a 4.6% stake in IMMUNE DESIGN CORP.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy